CHS (CYH) Reports Q1 2026 Earnings with Declines in Adjusted EBITDA and Same-Store Admissions
CHS Inc. (CYH) reported Q1 2026 earnings with a 17.8% year-over-year decline in adjusted EBITDA to $309 million. Same-store net revenue increased 3.1% due to higher net revenue per admission, but was partially offset by declines in same-store admissions, surgeries, and ED visits. The company also noted a decrease in contract labor spend and improvements in supplies expense.
Tickers: $CHSCL
Topics: debt reduction earnings EBITDA financial performance operational metrics revenue